Search Within

Carissa Ellen Chu

Formats
  1. Journal Article (6)
  2. Meeting Abstract (5)
  3. Review (2)
  4. Book Section (1)
  5. Editorial (1)
Groups
  1. GME, Urology (15)
  2. Graduate Medical Education (15)
  3. Department of Medicine (13)
  4. Genitourinary Oncology Service (13)
  5. Solid Tumor Oncology Division (13)
  6. Surgery (13)

More Groups

People
  1. Gopakumar Iyer (11)
  2. David Solit (10)
  3. Hikmat Al-Ahmadie (9)
  4. Jonathan Rosenberg (9)
  5. Bernard Bochner (8)
  6. Eugene Pietzak (8)

More People

Years
  1. 2025 (3)
  2. 2024 (1)
  3. 2023 (6)
  4. 2022 (4)
  5. 2021 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. Clinical Cancer Research (2)
  3. European Urology (2)
  4. Cell Reports (1)
  5. Comprehensive Diagnostic Approach to Bladder Cancer: Molecular Imaging and Biomarkers (1)
  6. European Journal of Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. American Association for Cancer Research (2)
  3. Elsevier Inc. (2)
  4. Elsevier Science, Inc. (2)
  5. Nature Publishing Group (2)
  6. Cell Press (1)

More Publishers

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer
    Journal Article

    Chang, K.; Delavan, H. M.; Yip, E.; Kasap, C.; Zhu, J.; Lodha, R.; Liao, S. Y.; Berman, S. C.; Carretero-Gonzalez, A.; Basar, M.; more...
    Nature Communications (2025)

    Fulltext@MSK | Save
  • Clinical outcomes, genomic heterogeneity, and therapeutic considerations across histologic subtypes of urothelial carcinoma
    Journal Article

    Chu, C. E.; Chen, Z.; Whiting, K.; Ostrovnaya, I.; Lenis, A. T.; Clinton, T. N.; Rammal, R.; Ozcan, G. G.; Akbulut, D.; Basar, M.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Molecular heterogeneity and immune infiltration drive clinical outcomes in upper tract urothelial carcinoma
    Journal Article

    Kim, K.; Alam, S. M.; Kuo, F.; Chen, Z.; Yip, W.; Katims, A. B.; Chu, C.; Lenis, A. T.; Hu, W.; Gokturk Ozcan, G.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Natural history and genomic landscape of chemotherapy-resistant muscle-invasive bladder cancer
    Journal Article

    Lenis, A. T.; Whiting, K.; Ravichandran, V.; Tallman, J. E.; Alam, S. M.; Chu, C. E.; De Jesus Escano, M.; Bochner, E.; Katims, A.; Reisz, P. A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Immune mechanisms and molecular therapeutic strategies to enhance immunotherapy in non–muscle invasive bladder cancer: Invited review for special issue "Seminar: Treatment Advances and Molecular Biology Insights in Urothelial Carcinoma"
    Review

    Chu, C.; Pietzak, E.
    Urologic Oncology: Seminars and Original Investigations (2023)

    Fulltext@MSK | Save
  • Clinical and genomic landscape of FGFR3-altered urothelial carcinoma and treatment outcomes with erdafitinib: A real-world experience
    Journal Article

    Guercio, B. J.; Sarfaty, M.; Teo, M. Y.; Ratna, N.; Duzgol, C.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Regazzi, A. M.; Chen, Z.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Genomic landscape of urothelial carcinoma with divergent differentiation and histologic subtypes
    Meeting Abstract

    Chu, C.; Chen, Z.; Whiting, K.; Rammal, R.; Lenis, A.; Ozcan, G. G.; Akbulut, D.; Basar Yerebakan, M.; Chen, J. F.; Sirintrapun, S. J.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Scratching the surface: NECTIN-4 as a surrogate for enfortumab vedotin resistance
    Editorial

    Aggen, D. H.; Chu, C. E.; Rosenberg, J. E.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Response Evaluation Criteria in Tumors of the Bladder (RECIT-Bladder) for future window of opportunity trials as a platform to accelerate drug development
    Meeting Abstract

    Gaffney, C.; Jiang, S.; de Jesus, M. R.; Chu, C. E.; Benfante, N.; Bajorin, D. F.; Donahue, T. F.; Rosenberg, J. E.; Iyer, G.; Bochner, B. H.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Assessing the utility of a cell-free tumor (ct)DNA assay (MSK-ACCESS) in patients (pts) with node-positive (N+) muscle-invasive bladder cancer (MIBC) undergoing neoadjuvant chemotherapy (NAC)
    Meeting Abstract

    Katims, A. B.; Lenis, A. T.; Shah, R. H.; Chu, C. E.; Ratna, N.; Regazzi, A. M.; Pietzak, E. J.; Aggen, D. H.; Funt, S. A.; Teo, M. Y.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save